STOCK TITAN

ROCKET PHARMACEUTICALS (RCKTW) Stock Price, News & Analysis

RCKTW NASDAQ

Company Description

ROCKET PHARMACEUTICALS (NASDAQ: RCKTW) is classified in the Pharmaceutical Preparations sector.

RCKTW has declined 92.0% over the past year. Shares last traded at $0.0033.

For FY2025, ROCKET PHARMACEUTICALS reported revenue of $0 with net income of -$223.1M and diluted earnings per share of $-2.01.

This page collects what Stock Titan holds for RCKTW, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$0.0022
-33.33%
0.00
Last updated: July 29, 2026 at 10:51
-92.0%
Performance 1 year

ROCKET PHARMACEUTICALS (RCKTW) stock last closed at $0.0033. Over the past 12 months, the stock has lost 92.0%.

See what a $1,000 investment in RCKTW would be worth today

RCKTW Rankings

Latest News

No recent news available for RCKTW.

SEC Filings

ROCKET PHARMACEUTICALS has filed 5 recent SEC filings, including 3 Form 4, 1 Form 3, 1 Form 144. The most recent filing was submitted on July 8, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all RCKTW SEC filings →

Financial Highlights

operating income reached -$231.7M, and net income was -$223.1M. Diluted earnings per share stood at $-2.01. The company generated -$190.0M in operating cash flow. With a current ratio of 6.38, the balance sheet reflects a strong liquidity position.

$0
Revenue (FY2025)
-$223.1M
Net Income (FY2025)
-$190.0M
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in ROCKET PHARMACEUTICALS (RCKTW) currently stands at 146.4 thousand shares, up 3848.2% from the previous reporting period. Since July 2025, short interest has increased by 6405.5%.

Days to Cover History

Last 12 Months

Days to cover for ROCKET PHARMACEUTICALS (RCKTW) currently stands at 2.9 days, up 190% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 190% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 29.8 days.

RCKTW Company Profile & Sector Positioning

ROCKET PHARMACEUTICALS (RCKTW) operates in the Pharmaceutical Preparations sector and is listed on the NASDAQ.

Frequently Asked Questions

What is the current stock price of ROCKET PHARMACEUTICALS (RCKTW)?

The current stock price of ROCKET PHARMACEUTICALS (RCKTW) is $0.0033 as of July 28, 2026.

What is the revenue of ROCKET PHARMACEUTICALS (RCKTW) stock?

The FY2025 revenue of ROCKET PHARMACEUTICALS (RCKTW) is $0, from its most recent completed fiscal year.

What is the net income of ROCKET PHARMACEUTICALS (RCKTW)?

The FY2025 net income of ROCKET PHARMACEUTICALS (RCKTW) is -$223.1M, from its most recent completed fiscal year.

What is the earnings per share (EPS) of ROCKET PHARMACEUTICALS (RCKTW)?

The diluted earnings per share (EPS) of ROCKET PHARMACEUTICALS (RCKTW) is $-2.01 for FY2025, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of ROCKET PHARMACEUTICALS (RCKTW)?

The operating cash flow of ROCKET PHARMACEUTICALS (RCKTW) is -$190.0M. Learn about cash flow.

What is the current ratio of ROCKET PHARMACEUTICALS (RCKTW)?

The current ratio of ROCKET PHARMACEUTICALS (RCKTW) is 6.38, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of ROCKET PHARMACEUTICALS (RCKTW)?

The operating income of ROCKET PHARMACEUTICALS (RCKTW) is -$231.7M. Learn about operating income.